Due to the difficulty in obtaining ocular posterior pole tissues from subjects with nonpathologic myopia, the expression patterns of cochlin and SFRP-1, the 2 actionable targets identified in this study, have not been validated in clinical samples. The gene discussed is COCH; the disease is myopia.